Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63380	356	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
63193	Can anyone share the text from this article? Thanks The Sarepta Mugging and Dru	ghettogoulash	-	7/27/2025
63192	Fwiw, Ingram said in May that it was the FDA who suggested adding Sirolimus to t	ghettogoulash	3	7/26/2025
63191	Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS BUSINESS WIRE Ju	luckydog88	1	7/26/2025
63190	Thanks GG for posting this. What I found particularly interesting is that this m	bodish	1	7/25/2025
63189	REUTERS Jul-25-2025 5:50 p.m. ET July 25 (Reuters) - The U.S. Food and Drug Ad	luckydog88	-	7/25/2025
63188	REUTERS Jul-25-2025 6:42 a.m. ET July 25 (Reuters) - Europe's medicines re	luckydog88	1	7/25/2025
63187	Great finds GG. AF’s prognistication that this could completely sink Sarepta see	Olecranon	1	7/25/2025
63186	Yet another mother explains the risk/reward elegantly. These Elevidys stories ar	ghettogoulash	2	7/24/2025
63185	Roche also wonders wtf is up with the FDA. Meanwhile, Laura Loomer is on a crusa	ghettogoulash	3	7/24/2025
63184	Preceding that, more fake news: [graphic][graphic][graphic]	ghettogoulash	1	7/24/2025
63183	found this hitting the wire at 3:22 Endpoints News Biotech/Pharma Reporter Zac	luckydog88	2	7/24/2025
63182	Added more SRPT a little while ago in the mid-10's. But I was afraid to buy	Olecranon	-	7/24/2025
63181	SRPT: talk about a divergence of analyst opinions this morning ........ Citigr	luckydog88	1	7/24/2025
63180	Interesting that Goldman Sachs just downgraded IOVA (to $1.00), we all remember	Stikkmann	1	7/23/2025
63179	Anyone following IOVA? Seems to be moving with good volume. Thoughts? TIA	CFL Invest 1	1	7/22/2025
63178	I wasn't crazy about Sarepta defying FDA brass, but I could see why they did	ghettogoulash	1	7/22/2025
63177	CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (SRPT) , the lead	luckydog88	-	7/21/2025
63176	Don't know much about RFK, but his recent comments do not seem threatening,	ghettogoulash	-	7/21/2025
63175	Elevedis is in ambulatory patients has quickly jumped over PMO as SRPT’s greates	Olecranon	-	7/21/2025
63174	certainly looks like RFK is out to get them, whether it is deserved in some case	luckydog88	1	7/21/2025
63173	This doesn't look like good news: investorrelations.sarepta.com Excerpts:	erickerickson	-	7/21/2025
63172	Sarepta issues letter to Duchenne community: share.google	ghettogoulash	3	7/19/2025
63171	Dr. Marty Makary, the F.D.A. commissioner, said in the agency’s statement that i	ghettogoulash	1	7/18/2025
63170	There was a plea today on STAT news from two activist mothers of Duchenne patien	ghettogoulash	2	7/18/2025
63169	CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (SRPT) , the lead	luckydog88	1	7/18/2025

Go to reply# or date (mm/dd/yy):